We're pleased that Zeeks is partnering with Convenzis as a media partner, supporting its upcoming programme of NHS healthcare events and helping share the ideas, insights and practical experiences coming out of these conversations. We recently spoke to Sean McLaughlin, Director of Convenzis Group, to find out more about Convenzis, why healthcare events are changing and who should be attending.

Writing a scientific blog is easy. Writing a scientific blog that actually drives traffic is not. Most blogs fail to actually be useful as they are written for the wrong reader, structured for no one, and invisible to search engines (especially generative search engines). If you want your blog to attract the right audience, you need to treat it as both scientific communication and strategic content. This guide explains how to write a scientific blog that drives traffic.

Biotech startups operate in a highly demanding communication environments. You are expected to demonstrate scientific credibility, commercial relevance, and ethical responsibility; most of it even before market entry. This is why a science marketing strategy for biotech startups cannot be improvised or copied from general consumer brands. It must be designed specifically for scientific audiences, long development timelines, and trust-based decision making.

B2B marketing in the sciences is definitely different to generic marketing. Not only are scientific discoveries and biotechnology developments complex, but they are also often taking a long time, have high stakes, and require trust by customers and/or end-users. Thus, if you want to market to scientists, engineers, clinicians, or technically literate decision-makers, traditional B2B marketing playbooks will fail you.

Communicating science clearly and effectively isn’t always easy, but given that funding, investments, and sales depend on how well you communicate, the need for science communication is non-negotiable. This can be made easier by bringing in external creative teams with expertise and experience in how to showcase your science through excellent science communication.

Over the past decade, China has transformed its pharmaceutical sector, evolving from a generics-dominated market into a global engine for innovative drug development. This shift has been driven by a combination of regulatory reforms, substantial increases in research and development (R&D) investment, and the rapid expansion of clinical research and manufacturing capabilities. This article explores the key drivers behind China’s rise in innovative drug development.